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Newly assembled snRNPs associate with coiled bodies before
speckles, suggesting a nuclear snRNP maturation pathway
Judith E. Sleeman and Angus I. Lamond
Background: Small nuclear ribonucleoproteins (snRNPs), which are essential
components of the mRNA splicing machinery, comprise small nuclear RNAs,
each complexed with a set of proteins. An early event in the maturation of
snRNPs is the binding of the core proteins — the Sm proteins — to snRNAs in
the cytoplasm followed by nuclear import. Immunolabelling with antibodies
against Sm proteins shows that splicing snRNPs have a complex steady-state
localisation within the nucleus, the result of the association of snRNPs with
several distinct subnuclear structures. These include speckles, coiled bodies
and nucleoli, in addition to a diffuse nucleoplasmic compartment. The reasons
for snRNP accumulation in these different structures are unclear.
Results: When mammalian cells were microinjected with plasmids encoding
the Sm proteins B, D1 and E, each tagged with either the green fluorescent
protein (GFP) or yellow-shifted GFP (YFP), a pulse of expression of the tagged
proteins was observed. In each case, the newly synthesised GFP/YFP-labelled
snRNPs accumulated first in coiled bodies and nucleoli, and later in nuclear
speckles. Mature snRNPs localised immediately to speckles upon entering the
nucleus after cell division.
Conclusions: The complex nuclear localisation of splicing snRNPs results, at
least in part, from a specific pathway for newly assembled snRNPs. The data
demonstrate that the distribution of snRNPs between coiled bodies and
speckles is directed and not random.
Background
Within the nucleus, which houses the cell’s chromosomes,
many complex pathways need to be coordinated. Unlike
the cytoplasm, the nucleus is not compartmentalised into
membrane-bound organelles. Many nuclear antigens are,
however, localised in different subnuclear structures, dis-
tinct from the surrounding nucleoplasm, that can be
resolved by both light and electron microscopy (for recent
reviews, see [1–4]). The most obvious structure in the inter-
phase nucleus is the nucleolus, which contains the riboso-
mal gene clusters and is the site of ribosome production. It
may also have other roles in RNA metabolism and transport
[5]. A variety of other nuclear bodies and structures have
also been described, including coiled bodies, ‘gemini’ of
coiled bodies (‘gems’), promyelocytic leukaemia (PML)
bodies, interchromatin granule clusters, interchromatin-
granule-associated zones and perichromatin fibrils [6–17]. 
Early events in the maturation of small nuclear ribonucleo-
proteins (snRNPs) are known to occur in the cytoplasm.
Following their transcription in the nucleus, snRNAs are
transported to the cytoplasm where the Sm proteins bind
and the 5′ end of the snRNA is modified to form the char-
acteristic trimethylguanosine (TMG) cap (Figure 1). These
events are essential for the re-import of newly made
snRNPs into the nucleus [18–21]. The Sm proteins [22] are
a group of seven polypeptides (B/B′, D1, D2, D3, E, F and
G) [19,23] that form stable subcomplexes before their
assembly onto snRNAs [24–26]. The Sm subcomplexes
D1–D2 and E–F–G form a stable partial complex with
snRNA, with the subsequent addition of D3–B/B′ complet-
ing the core, seven-protein Sm snRNP complex [26]. It has
recently been proposed that the Sm protein complex forms
a seven-membered ring around the snRNA [27]. Additional
events required for the production of a fully mature snRNP
particle include the addition of snRNP-specific proteins
and numerous base and sugar modifications of the snRNA
itself [28]. The location of the snRNA modification reac-
tions is unknown, although it has been demonstrated that a
small nucleolar RNA (snoRNA) can act as a guide to direct
2′-O-methylation of U6 snRNA [29].
Immunostaining of cells with antibodies to Sm proteins
demonstrates that snRNPs have a complex nuclear locali-
sation, comprising a punctate staining pattern with an
additional diffuse component. The punctate pattern is
formed by snRNPs interacting with different subnuclear
structures, including mainly interchromatin granule cluster
speckles, perichromatin fibrils and coiled bodies [14,15].
The diffuse nucleoplasmic snRNP staining most likely
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includes snRNPs actively involved in splicing of nascent
transcripts [30–34].
Here, by fusing Sm proteins to fluorescent protein tags
based on the green fluorescent protein (GFP), we
analysed the interaction of newly assembled snRNPs with
nuclear structures following their initial import into the
nucleus. Nascent snRNPs were seen to accumulate first in
coiled bodies and, only at later times, in speckles. The
data are consistent with a directed movement of snRNPs
from coiled bodies to speckles during their maturation.
Results
Expression of fluorescent-tagged versions of Sm proteins
as single fusion proteins in a variety of cell types
To analyse the kinetics of snRNP localisation, we tagged
three separate Sm proteins (SmB, SmD1 and SmE) with
either GFP or yellow-shifted GFP (YFP). The tagged Sm
proteins were chosen to include members of each of the
three Sm protein subcomplexes that assemble into the
seven-protein Sm complex with snRNA [24–26]. We have
recently described plasmid phGFP–SmE which expresses,
under the control of the cytomegalovirus (CMV) promoter,
the S65T mutant of human GFP (hGFP-S65T) fused in
frame at the amino terminus of full-length human SmE
[35]. Two additional plasmids were constructed. One
expresses full-length human SmD1 tagged at its amino
terminus with enhanced GFP (pEGFP–SmD1, see Mate-
rials and methods). The second expresses full-length
human SmB tagged at its amino terminus with enhanced
YFP (pEYFP–SmB, see Materials and methods). These
plasmids also used the CMV promotor to drive expression
of the fusion protein (Figure 2a).
To characterise the expression of the two new fusion pro-
teins, whole cell lysates were prepared from HeLa and
293 cells following transient transfection with plasmids
pEYFP–SmB and pEGFP–SmD1. Approximately 80% of
cells expressed the tagged Sm protein at the time of lysis
(data not shown). The lysates were separated by
SDS–PAGE, transferred to nitrocellulose membrane and
probed with an antibody that recognises GFP and YFP
(Figure 2b). Each of the fusion proteins was detected as a
single band of the expected size. We conclude that any
GFP/YFP fluorescence seen in cells transfected with
these plasmids results from the fusion proteins, rather
than from free GFP. Nitrocellulose membranes prepared
in the same way were probed with the anti-Sm antibody
Y12 [36] (Figure 2b). Endogenous SmB protein was
detected in all cell lysates, with a larger band correspond-
ing to the EYFP–SmB fusion protein detected only in
lysates of cells expressing pEYFP–SmB. The intensity of
the EYFP–SmB band was significantly lower than that of
the endogenous SmB protein, indicating that there was
not a vast overexpression of the Sm proteins in transfected
cells. The incorporation of the tagged Sm proteins into
snRNP particles was confirmed by affinity purification of
snRNPs from transfected HeLa cells using a monoclonal
antibody that recognises the TMG cap of the snRNA
(Figure 2c). EGFP–SmD1 and endogenous Sm proteins
were found exclusively in the affinity purified snRNP
fraction, with none detected in the unbound fraction. In
contrast, EGFP expressed alone was found exclusively in
the unbound fraction, with none copurifying with the
snRNPs. Additional experiments using anti-TMG cap
antibodies indicated that both the EYFP–SmB and
hGFP–SmE fusion proteins were also assembled into
snRNP particles (data not shown, see also [35]).
GFP/YFP-tagged Sm proteins show the same localisation
as endogenous Sm proteins
To determine the distribution patterns of the tagged Sm
proteins, HeLa and MCF-7 cells were fixed 24 hours after
transient transfection with pEYFP–SmB, pEGFP–SmD1
or phGFP–SmE and analysed by confocal fluorescence
microscopy (Figure 3, see also [35]). We saw a pattern of
speckles, coiled bodies and diffuse staining, consistent
with previously published Sm protein localisation data
[14,15]. We conclude that each of the tagged Sm fusion
proteins is expressed as a full-length protein, incorporated
into snRNP particles, imported into the nucleus and
localised in an identical pattern to endogenous snRNPs.
Newly made snRNPs accumulate in coiled bodies before
speckles
To specifically detect newly assembled snRNPs, we made
use of the fact that Sm proteins must be assembled onto
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Figure 1
Maturation of a splicing snRNP. Following its transcription in the
nucleus, a nascent snRNA is exported to the cytoplasm where it forms
a complex with the core, Sm, proteins. Hypermethylation to form the
TMG cap structure then takes place. Only then is the partially mature
snRNP particle re-imported into the nucleus.
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the newly synthesised snRNA in the cytoplasm before the
nascent snRNP particle can be re-imported into the
nucleus. Cells were analysed by confocal fluorescence
microscopy at different times following micro-injection
with plasmids encoding the respective tagged Sm fusion
protein. Following injection, only a short burst of expres-
sion of the fusion protein was observed, most likely the
result of rapid degradation of the naked plasmid DNA
inside the cells. The observed pulse of expression facili-
tated kinetic studies. Newly assembled snRNPs, made flu-
orescent with the respective tagged Sm fusion protein,
each showed similar, time-dependent, expression patterns
both in fixed cells (Figure 4) and in live cells. The ‘mature’
punctate pattern, including speckles and coiled bodies (the
pattern seen using antibodies to endogenous Sm proteins),
was observed only at longer time points following microin-
jection (Figure 4d,i,n). Shortly after microinjection
(1–4 hours), a weak diffuse signal was seen throughout the
whole cell, including the cytoplasm (Figure 4a,f,k). Next,
an accumulation in coiled bodies was evident
(Figure 4b,g,l). This was confirmed by counterstaining
with anti-p80 coilin antibodies (data not shown; see also
below). Quantitation of the fluorescence indicated that
approximately 2% of the signal due to tagged Sm protein in
the nucleus was concentrated in coiled bodies at this stage.
This result is similar to that obtained previously using anti-
sense probes to detect endogenous U2 snRNA [37].
The next pattern seen included localisation of the tagged
Sm protein within nucleoli and in coiled bodies
(Figure 4c,h,m). At these early stages (1–6 hours after
microinjection), little or no accumulation of the labelled
snRNP was detected in speckles, although a diffuse
nuclear compartment was clearly visible. At 6–15 hours
after microinjection, labelled snRNPs showed the ‘steady
state’ punctate Sm protein distribution that colocalised
with endogenous Sm proteins (Figure 4d,i,n and data not
shown). This pattern included diffuse nucleoplasmic
staining, speckles and coiled bodies. Later still, the associ-
ation of labelled snRNPs with coiled bodies decreased
(Figure 4e,j,o; see also below). At later time points, the
cytoplasmic signal was also absent, indicating that expres-
sion of the tagged Sm fusion protein had ceased and that
the existing fusion proteins had all been chased into the
nucleus. These data show that newly made snRNPs accu-
mulate in the coiled body and nucleolus before accumula-
tion in speckles. The loss of fluorescent Sm signal from
coiled bodies at later time points, when the cytoplasmic
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Figure 2
GFP/YFP-tagged Sm proteins are expressed as single fusion proteins
and assembled into snRNPs. (a) Schematic illustration of the
expression plasmids used in this study. See the Materials and methods
for details on how pEYFP–SmB and pEGFP–SmD1 were constructed.
Plasmid phGFP–SmE has been described previously [35].
(b) SDS–PAGE analysis of whole cell lysates from cells transiently
transfected with pEYFP–SmB or pEGFP–SmD1. Lanes 1–3 and 6–8,
lysates from HeLa cells transfected without DNA (lanes 1,6), or with
pEYFP–SmB (lanes 2,7) or pEGFP–SmD1 (lanes 3,8); lanes 4,5,9,10,
lysates from 293 cells transfected with pEYFP–SmB (lanes 4,9) or
pEGFP–SmD1 (lanes 5,10). Lanes 1–5 were probed with a mixture of
monoclonal antibodies to GFP (Roche); single bands were detected at
the sizes predicted for EYFP–SmB (56 kDa) and EGFP–SmD1
(42 kDa). No bands were detected in control HeLa cells (lane 1) or
293 cells (data not shown) exposed to the transfection reagent in the
absence of DNA. A duplicate blot (lanes 6–10) probed with the anti-
Sm antibody Y12 allowed detection of the EYFP–SmB fusion protein
in HeLa cells (lane 7) and 293 cells (lane 9). Cells transfected without
DNA (lane 6) or with pEGFP–SmD1 (lanes 8,10) showed a doublet of
bands at 28/29 kDa, representing endogenous SmB and SmB′.
(c) Affinity purification of snRNPs, using antibodies against the TMG
cap, from HeLa cells transfected with pEGFP–SmD1 (lanes 1–6) or
plasmid expressing EGFP alone (pEGFP-C1; lanes 7–9).
EGFP–SmD1 was detected in the purified snRNP fraction (lane 3)
using an anti-GFP monoclonal antibody, but was absent from the
unbound fraction (lane 2) and from cell lysate incubated with control
beads without anti-TMG antibody (lane 1). A duplicate blot stained
with antibody Y12 confirmed that endogenous Sm proteins were also
present specifically in the purified snRNP fraction (lane 6) but not in
the unbound fraction (lane 5) or the control bead fraction (lane 4).
Conversely, in a lysate from cells transfected with pEGFP-C1, EGFP
was found only in the unbound fraction (lane 8) and was absent from
the purified snRNP fraction (lane 9) and the control beads (lane 7).
Additional bands in the snRNP fraction (lanes 3,6,9) result from cross-
reaction of the anti-mouse secondary antibodies with the anti-TMG
monoclonal antibody bound to the beads.
signal was also no longer seen, suggests that this initial
interaction with the coiled body is a transitory one.
Indeed, preliminary evidence from fluorescence recovery
after photobleaching (FRAP) experiments indicated that
snRNPs move rapidly into coiled bodies and must, there-
fore, also leave coiled bodies rapidly, because the fluores-
cence signal did not continue to increase with time (our
unpublished observations). 
When the percentage of cells showing each localisation
pattern is plotted against time, the early accumulation of
labelled snRNPs in coiled bodies and nucleoli and later
localisation to speckles is clear (Figure 5). The changing
temporal localisation patterns are not caused by attaching
the fluorescent-protein tag onto the Sm proteins, because
we observed a similar time-dependent change in localisa-
tion pattern following micro-injection of a plasmid vector
that expresses SmE tagged at its amino terminus with a
Myc epitope tag (data not shown).
Kinetics of snRNP localisation in living cells
Time-lapse fluorescence microscopy of living HeLa cells
expressing EGFP–SmD1 confirmed that the newly made
snRNPs, labelled with GFP/YFP-tagged Sm proteins,
accumulated first in coiled bodies then in the nucleolus
(Figure 6a,b). Cells showing EGFP–SmD1 accumulation
in coiled bodies were imaged once every 10 minutes over
a 240 minute time course. An increase in EGFP–SmD1
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Figure 3
Sm proteins tagged with GFP or YFP show nuclear localisations
identical to endogenous Sm proteins. Confocal fluorescence
micrographs (upper panels) and corresponding Nomarski images (lower
panels) of (a,b) MCF-7 cells and (c) HeLa cells transiently transfected
with (a) pEYFP–SmB, (b) pEGFP–SmD1, or (c) phGFP–SmE, and
fixed 24 h after transfection. The bars represent 10 µm.
(a) (b) (c)
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Figure 4
(a–e) Three-dimensional projections of serial
confocal sections through MCF-7 cells
expressing pEYFP–SmB, fixed 1, 2, 4, 7 and
16 h, respectively, after microinjection.
(a) After 1 h, EYFP–SmB was present
throughout the cytoplasm and nucleus, with
no preferential localisation to nuclear
structures, but (b) 2 h after injection, there
was some concentration in the coiled body
(arrow). (c) After 4 h, many cells showed
accumulation of EYFP–SmB in coiled bodies
(arrow) and nucleoli (arrowhead) in addition
to the diffuse signal throughout the cell.
(d) By 7 h, most cells showed EYFP–SmB
localisation to speckles (arrowheads) and the
coiled body (arrows). The cytoplasmic signal
was still seen. (e) By 16 h, most cells showed
EYFP–SmB in nuclear speckles
(arrowheads), with no pronounced
accumulation in coiled bodies. The
cytoplasmic signal was no longer seen.
(f–j) Single confocal sections of MCF-7 cells
expressing pEGFP–SmD1, fixed 1, 2, 4, 9
and 24 h, respectively, after injection.
(f) EGFP–SmD1 was found throughout the
cytoplasm and nucleus 1 h after injection, but
(g) was concentrated in the coiled body
(arrows) 2 h after injection. (h) Accumulation
in coiled bodies (arrow) and nucleoli
(arrowheads) was seen after 4 h. (i) After 9 h,
EGFP–SmD1 localised to speckles
(arrowheads) and coiled bodies (arrows).
(j) By 24 h, most cells showed EGFP–SmD1
in nuclear speckles (arrowheads), with no
pronounced accumulation in coiled bodies.
The cytoplasmic signal was no longer seen.
(k–o) Single confocal sections of MCF-7
cells expressing phGFP–SmE, fixed 4, 5, 6, 8
and 16 h, respectively, after injection. (k) After
4 h, hGFP–SmE was diffuse throughout the
cytoplasm and nucleus (top cell), but (l)
showed concentration in the coiled body
(arrow) 5 h after injection. (m) After 6 h,
hGFP–SmE showed accumulation in coiled
bodies (arrow) and nucleoli (arrowhead), and
(n) after 8 h, localisation to speckles
(arrowheads) and coiled bodies (arrows).
(o) After 16 h, hGFP–SmE was seen in
nuclear speckles (arrowheads), with no
pronounced accumulation in coiled bodies.
The cytoplasmic signal was no longer seen.
The bars represent 10 µm.
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signal in the nucleolus with time was observed. The
EGFP–SmD1-containing coiled bodies maintained rela-
tively constant positions in the nucleus during this time
period, both with respect to each other and to the nucleoli.
In a separate experiment, MCF-7 cells expressing
hGFP–SmE and showing nucleolar accumulation of
labelled snRNP, together with a low level of snRNP accu-
mulation in speckles, were imaged every 20 minutes over
100 minutes (Figure 6c). During this time, the intensity of
the signal in the speckles increased and these structures
became more distinct. Preliminary quantitative analysis
suggested that the percentage of fluorescent signal in
speckles increased approximately twofold during this time
course. These data confirm that newly made snRNPs
show a temporal variation in localisation in living cells.
Coiled bodies are the first site of accumulation of nascent
snRNPs, with subsequent accumulation in the nucleolus
and finally in speckles. Diffuse nucleoplasmic snRNP
staining was seen throughout.
GFP-tagged non-snRNP protein splicing factors do not
localise in coiled bodies and nucleoli at early time points
The initial targeting to coiled bodies and nucleoli appears
to be a feature unique to Sm proteins, and is not seen with
other non-snRNP protein splicing factors. For example,
GFP-tagged splicing factors, such as ASF/SF2 (Figure 7),
and GFP fusions to both subunits of U2AF (data not
shown), were seen in nuclear speckles as soon as the GFP
fluorescence was intense enough to be detected in the
nucleus (2.5 hours after microinjection for ASF/SF2,
2 hours for U2AF35 and U2AF65). These protein splicing
factors enter the nucleus faster than Sm proteins, probably
because they do not have a requirement for pre-assembly
onto snRNA for nuclear entry. We conclude that the
initial concentration of Sm proteins in coiled bodies is not
a feature of either nuclear proteins in general, or of all
spliceosome factors.
The temporal patterns of Sm protein localisation do not
result from a general disruption of nuclear structure
The dynamic temporal change in snRNP localisation was
not caused by microinjection of the plasmid DNA as
similar patterns of localisation of the GFP/YFP-tagged Sm
proteins could be seen when cells were fixed at early time
points following transient transfection. The expression of
EYFP–SmB, EGFP–SmD1 and hGFP–SmE was less syn-
chronous after transfection, as compared with microinjec-
tion, presumably because the cells are in contact with the
DNA mixture for an extended period of time, take up the
DNA with varying efficiency and therefore begin to
express the exogenous genes at different times. Neverthe-
less, the use of transfection protocols allowed a much
larger number of cells to be studied. Counterstaining of
transfected cells transfected with the Y12 antibody, which
recognises primarily SmB and SmB′, and with anti-p80
coilin antibodies, confirmed that, at early time points,
endogenous Sm proteins showed a pattern of staining in
coiled bodies and speckles, and diffuse nucleoplasmic
staining, identical to that seen in untransfected cells
(Figure 8a–d and data not shown). In these cells, the fluo-
rescent-labelled snRNP was diffusely distributed with
accumulation in coiled bodies and nucleoli, but not in
speckles. This shows that the early temporal localisation
patterns of GFP/YFP-tagged Sm proteins do not result
from a disruption of nuclear speckled structures caused by
expression of the tagged proteins. 
At late time points (64 hours after transfection), speckles
containing both labelled and endogenous snRNPs were
detected. Many cells expressing the tagged Sm proteins
did not contain prominent coiled bodies when stained
with Y12 or anti-coilin antibodies (Figure 8e–h and data
not shown). Untransfected cells at late time points and
both transfected and untransfected cells at all other time
points contained an average of 2.7 coiled bodies per cell.
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Figure 5
Time-dependent localisation of GFP/YFP-
tagged Sm proteins. The percentages of cells
showing different localisation patterns of
GFP/YFP-tagged Sm protein were plotted
against time. Each data set was obtained by
injecting 150 cells for fixation at each time
point and counting every cell expressing
GFP/YFP-tagged Sm protein. The data shown
are representative of three separate
experiments for pEGFP–SmD1 and
phGFP–SmE and two experiments for
pEYFP–SmB. For pEYFP–SmB, cells
showing signal in the nucleolus and in coiled
bodies (CBs) have been plotted separately
from those showing accumulation of
EYFP–SmB in coiled bodies alone to
emphasise that the nucleolar signal is seen
later than the coiled-body signal.
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In transfected cells at the 64 hour time point, the average
was 0.6 coiled bodies per cell. It is possible that the forma-
tion of coiled bodies depends on the total level of snRNP
expression, which may, in turn, be influenced by expres-
sion of tagged Sm proteins.
Mature GFP-tagged snRNPs return directly to ‘speckles’
following mitosis
We next determined whether the temporal pattern of Sm
protein localisation was unique to newly assembled
snRNPs, or rather was a general feature of snRNP import
into the nucleus. To test this, we analysed the localisation of
GFP-tagged Sm proteins in cells that had undergone
mitosis and then reimported the previously assembled
snRNPs into daughter nuclei. HeLa cells were fixed
48 hours after transient transfection with either
pEGFP–SmD1 or phGFP–SmE. At this time point, the
GFP–Sm signal was seen in speckles and coiled bodies.
Mitotic cells were identified and analysed by confocal
microscopy (Figure 9 and data not shown). In late telophase,
the localisation pattern of re-imported EGFP–SmD1 and
hGFP–SmE mirrored that of endogenous Sm proteins as
confirmed by counterstaining with antibodies to endoge-
nous Sm proteins (Y12) and to p80 coilin (data not shown).
The speckled pattern reformed rapidly in late telophase and
no preferential targeting of GFP–Sm proteins to coiled
bodies was seen for snRNPs reimported after mitosis. This
indicates that initial accumulation of snRNPs in coiled
bodies following nuclear import is a feature of newly made
snRNPs, rather than of GFP-tagged snRNPs per se.
Discussion
A temporal dimension to snRNP localisation
In this study, we used GFP/YFP-tagged Sm proteins to
study the kinetics of snRNP localisation when newly
assembled snRNP particles first enter the nucleus. A rela-
tively synchronous expression of the tagged protein was
obtained by microinjecting the expression plasmids into
HeLa or MCF-7 cells. Expression from the injected DNA
template was temporary, resulting in a pulse of tagged-
protein production. In both HeLa and MCF-7 cells,
EYFP–SmB, EGFP–SmD1 and hGFP–SmE each showed
similar changes in nuclear localisation that depended on
the time of expression. Initially, the cells showed diffuse
cytoplasmic and nucleoplasmic staining, then fluorescent-
labelled snRNPs accumulated in coiled bodies and nucleoli
(1–6 hours). At later times (6–15 hours), the GFP/YFP-
tagged snRNPs appeared in the characteristic speckled
pattern of endogenous snRNPs. Later still (beyond
24 hours), the labelled snRNPs showed only diffuse and
speckled nuclear localisation and no longer concentrated in
coiled bodies. By these late time points, the fluorescent Sm
signal was entirely nuclear. 
In contrast, when GFP-tagged non-snRNP protein splic-
ing factors, such as ASF/SF2 and U2AF, were transiently
expressed, they rapidly colocalised with their cognate
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Figure 7
GFP–ASF/SF2 localises to nuclear speckles as soon as it is
expressed. (a) Confocal micrograph and (b) corresponding Nomarski
image of a living MCF-7 cell 2.5 h after microinjection with
pGFP–ASF/SF2, encoding a fusion of ASF/SF2 to hGFP-S65T. Note
the strong signal in nuclear speckles and absence of localisation to
other nuclear structures. The bar represents 10 µm.
(a) (b)
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Figure 6
Time-lapse fluorescence microscopy demonstrates the sequential
accumulation of newly made snRNPs. (a,b) Images of two different
cells from a time-lapse sequence of HeLa cells transfected with
pEGFP–SmD1. The images were taken every 10 min over a 240 min
period. The cells initially showed a diffuse distribution of EGFP–SmD1
with additional accumulation in coiled bodies (arrows). Nucleolar
accumulation was first apparent after about 60 min (arrowheads). The
intensity of nucleolar signal increased throughout the time course.
(c) Images from a time-lapse sequence of MCF-7 cells transfected with
phGFP–SmE. The images were taken every 20 min over a 100 min
period. Initially, a pattern of diffuse nucleoplasmic staining with some
nucleolar accumulation and indistinct speckles was seen. During the
time course, the speckles became more distinct, while the nucleolar
accumulations remained unchanged. The bars represent 10 µm.
(a)
t = 0 min t = 60 min t = 180 min t = 240 min
t = 0 min t = 60 min t = 180 min t = 240 min
t = 0 min t = 40 min t = 80 min t = 100 min
(b)
(c)
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endogenous proteins to form a speckled pattern and did
not show time-dependent changes in localisation after
entering the nucleus. Furthermore, the time-dependent
change in snRNP localisation was not observed when
mature snRNPs re-entered the nucleus after mitosis. We
conclude that the sequential accumulation of snRNPs in
coiled bodies and then in speckles is not a general conse-
quence of nuclear import, but rather is a pathway for
newly assembled snRNPs. We suggest that this pathway
may have a role in snRNP maturation.
Accumulation of newly made snRNPs in coiled bodies
In the nucleus, accumulation of GFP/YFP-tagged snRNPs
was first detected in coiled bodies and only later in speck-
les. It is possible that the punctate localisation pattern of
mature labelled snRNP results from several independent
pathways of import into the nucleus (that is, separate
snRNP import pathways to coiled bodies, speckles and so
on), each with different kinetics. The subsequent loss of
labelled snRNP from the coiled body at later time points,
when cytoplasmic signal is also absent, suggests, however,
that there may be a flux of newly synthesised snRNPs
through the coiled body. If the targeting of snRNPs to
coiled bodies was simply faster, or of higher affinity, than
targeting to the nucleolus or speckles, it might be
expected that the interaction of labelled snRNPs with the
coiled body would also outlast their interactions with other
nuclear components and this is not the case. Furthermore,
following mitosis, tagged Sm proteins were re-imported
directly back into speckles, without showing any preferen-
tial localisation in coiled bodies at early time points. Again,
this suggests that the observed accumulation of labelled
snRNPs in coiled bodies at early time points does not
result from more rapid kinetics of entry into, or a higher
affinity for retention in, coiled bodies. The speckled struc-
tures are present in the nucleus and contain endogenous
snRNPs at the early time points of GFP/YFP-tagged Sm
protein expression. Despite speckles being more numer-
ous and occupying a larger nuclear volume than coiled
bodies, we show here that newly imported snRNPs do not
initially concentrate in speckles. The data thus demon-
strate that the distribution of snRNPs between coiled
bodies and speckles is directed and not random.
Evidence for the association of coiled bodies with snRNA
gene loci ([37–39]; reviewed in [40]) has been used to
propose an autologous feedback mechanism, whereby a
proportion of mature or partially mature snRNPs return to
coiled bodies adjacent to snRNA genes and regulate their
transcription [41]. A flux of newly made snRNPs through
coiled bodies would provide a mechanism to link tran-
scription of snRNA with maturation of snRNPs in such a
feedback mechanism. The present data are consistent
with this model. It is not clear whether all newly made
snRNPs, or just some of them, pass through the coiled
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Figure 8
The observed localisation patterns of newly made GFP/YFP-tagged
snRNPs do not result from disruption of nuclear structure. MCF-7
cells, transiently transfected with hGFP–SmE, were fixed (a–d) 16 h
and (e–h) 48 h after transfection. The confocal fluorescence
micrographs show (a,e) the fluorescence due to the GFP tag, and
staining with antibodies to (b,f) Sm proteins (Y12 antibody) and
(c,g) p80 coilin. (d,h) Overlay of (a–c) and (e–g) respectively. At 16 h,
(a) the hGFP–SmE signal was diffuse throughout the cell, with clear
accumulation in coiled bodies (arrows); (b) endogenous Sm proteins
were, as expected, localised to speckles (arrowheads) and coiled
bodies (arrows). (c) The anti-p80 coilin antibody confirmed the
presence of coiled bodies (arrows). (d) The merged image shows
hGFP–SmE colocalisation with endogenous Sm proteins in coiled
bodies (arrows) but not speckles (arrowheads) at this early time point.
(e) Later (48 h post-transfection), the hGFP–SmE signal was localised
to nuclear speckles (arrowheads) and less frequently to coiled bodies.
(f) Endogenous Sm proteins were also localised to nuclear speckles
(arrowheads) but not to coiled bodies. (g) The anti-p80 coilin antibody
showed that coiled bodies were present in only some of the cells
(arrow). (h) The merged image shows colocalisation of hGFP–SmE
with endogenous Sm proteins in speckles (arrowheads) at this time
point. Coiled bodies were present in 60% of cells (arrow), but were
not prominent. The bars represent 10 µm.
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Figure 9
Mature GFP-tagged snRNPs return directly to speckles after mitosis.
Confocal fluorescence micrographs (upper panels) and corresponding
phase-contrast images of (a) a metaphase cell expressing
hGFP–SmE, 48 h after transient transfection, and (b–d) cells
expressing hGFP–SmE at various stages of telophase. In (a), the
hGFP–SmE signal is diffuse throughout the cell. In (b–d), hGFP–SmE
returned directly to nuclear speckles following mitosis with no obvious
accumulation in coiled bodies. The bars represent 10 µm.
(a) (b) (c) (d)
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body. Preliminary data using FRAP suggested, however,
that labelled snRNPs flux quickly through the coiled body
(our unpublished data). EYFP–SmB re-accumulated in
coiled bodies within 1 minute following its bleaching with
a 488 nm laser. Our initial evidence from time-lapse fluo-
rescence microscopy indicated that coiled bodies contain-
ing newly made snRNPs do not show large movements,
either relative to each other or to nucleoli. If coiled bodies
are involved in a snRNP maturation pathway, this sug-
gests that their role may be as sorting points, rather than
transport vehicles. Nevertheless, we do not exclude the
possibility that, under some circumstances, coiled bodies
containing snRNPs also move through the nucleoplasm.
We have recently recorded examples of coiled body move-
ments in HeLa cells (M. Platani, J. Swedlow and A.I.L.,
unpublished data). Movement of nuclear coiled bodies has
also been described in plants expressing GFP fused to the
U2 snRNP B′′ protein [42].
A role for coiled-body interaction with the nucleolus in
snRNP maturation
GFP/YFP-tagged Sm proteins were first detected as a
diffuse signal followed by accumulation in coiled bodies. In
many cells, nucleolar accumulation was also seen. It is not
clear whether snRNPs interact first with the coiled body
and then with the nucleolus, or whether these are indepen-
dent events. Both were early events, however, and pre-
ceded the appearance of tagged Sm proteins in speckles.
Previous evidence points to a functional interaction
between coiled bodies and nucleoli. For example, expres-
sion of mutants of the coiled-body protein, p80 coilin, can
disrupt nucleolar structure [43]; conversely, mutant forms
of the nucleolar protein, Nopp140 [44], affect coiled-body
structure. In all tissue culture lines that we have tested, a
proportion of cells show low levels of nucleolar localisation
of snRNPs and p80 coilin. The present data suggest that
these accumulations may specifically represent newly syn-
thesised snRNPs. The level of snRNP in nucleoli can be
increased significantly either by inhibition of protein phos-
phorylation with okadaic acid or by transient expression of
a p80 coilin point mutant with a single serine to aspartate
substitution (S202D) [35,45]. Thus, protein phosphoryla-
tion may have a role in regulating snRNP localisation in
nucleoli. These observations will be used in future studies
to investigate whether a pathway exists for the directed
movement of snRNPs between coiled bodies and nucleoli.
It has been reported recently that fluorescently labelled U3
snoRNA, following its injection into the nuclei of Xenopus
oocytes, accumulates in sphere organelles (also known as
Xenopus coiled bodies) before nucleoli [46]. The authors
suggested a role for the Xenopus coiled body in the biogen-
esis and/or intranuclear transport of nucleolar snoRNAs,
and the work provides further evidence for functional
interactions between coiled bodies and nucleoli. The
Xenopus data are consistent with our present studies on
splicing snRNPs and the proposed role for the mammalian
coiled body in the maturation of nuclear RNP particles.
Nuclear speckles
In interphase nuclei, some nucleoplasmic splicing snRNPs
localised to speckles, which correspond largely to clusters
of interchromatin granules [14,15]. These nuclear speckles
were the last sites in which newly synthesised snRNPs,
detected by tagging with fluorescent protein, accumulated
following entry into the nucleus. Analysis of a GFP-tagged
version of the non-snRNP protein splicing factor ASF/SF2
showed that it localised rapidly to speckles without prior
accumulation in coiled bodies. The endogenous ASF/SF2
also showed speckled staining along with a diffuse nucleo-
plasmic pool. Recruitment of ASF/SF2 from speckles to
sites of active transcription has been demonstrated [47,48].
Additionally, overexpression of Clk/Sty or SRPK1/2
protein kinases, which have been shown to phosphorylate
ASF/SF2, results in a decrease in the localisation of
ASF/SF2 in speckles [49–52]. Our present data implicate
speckles as the probable end point of a putative snRNP
maturation pathway. The snRNPs accumulating in speck-
les are therefore likely to be mature. This is consistent
with the recent evidence showing that active splicing
factors are able to cycle between speckles and sites of
RNA polymerase II transcription.
Conclusions
The complex localisation pattern of splicing snRNPs
includes speckles and coiled bodies in addition to a diffuse
nucleoplasmic pool. This study suggests that the associa-
tion of snRNPs with different nuclear structures may
result, at least in part, from differences in the maturity of
the snRNPs, with newly made snRNPs accumulating in
the coiled body and nucleolus, whereas more mature
snRNPs accumulate in speckles. The existence of a
nuclear trafficking pathway for snRNP maturation raises
many interesting questions concerning the mechanism of
snRNP movement and how coiled bodies and other subnu-
clear structures are assembled and regulated. The Sm
fusion proteins described here may be useful for future
studies addressing nuclear dynamics in living cells.
Materials and methods
Plasmid constructs
The full-length human SmB cDNA was fused in frame with the EYFP
coding sequence as an EcoRI–SalI fragment in pEYFP-C1 (Clontech)
to make pEYFP–SmB. The full-length cDNA for human SmD1 was
fused in frame with the EGFP coding sequence as a BamHI–PstI frag-
ment in pEGFP-C1 (Clontech) to make pEGFP–SmD1.
Cell culture and transfection assays
HeLa, 293 and MCF-7 cells, obtained from ATCC, were grown in Dulbec-
co’s modified Eagles’ medium supplemented with 10% foetal calf serum
and 100 U/ml penicillin and streptomycin (Life Technologies). For immuno-
fluorescence assays, cells were grown on coverslips and transfected using
Fugene 6 (Roche) according to the manufacturer’s instructions. For the
preparation of cell lysates, cells were grown in 10 cm diameter dishes and
transfected using a modified calcium-phosphate-mediated transfection
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procedure with 1 µg/ml DNA per plate [53,54]. The cells were incu-
bated for 48 h before lysis.
Preparation of cell lysates and immunoblotting
Transfected cells were washed twice with ice-cold PBS and then lysed
in 0.5 ml ice-cold 50 mM Tris-HCl pH 7.5, 0.5 M NaCl, 1% (v/v) Nonidet
P-40, 1% (w/v) sodium deoxycholate, 0.1% (w/v) SDS, 2 mM EDTA plus
Complete protease inhibitor cocktail (Roche, one tablet per 25 ml). The
lysate was repeatedly passed through a 21G hypodermic needle to
break up the DNA and then cleared by centrifugation for 15 min at 4ºC
and 13000 × g. Lysates were electrophoresed on a 10% SDS–polyacry-
lamide gel and transferred to nitrocellulose membranes for immunoblot-
ting. Primary antibodies used were anti-GFP mouse monoclonal antibody
(Roche) and Y12 anti-Sm mouse monoclonal  antibody [36].
Immunoprecipitation of snRNP complexes
Lysates from HeLa cells expressing EGFP–SmD1 or EGFP were incu-
bated for 1 h on a shaking platform with 20 µl agarose beads coupled to
anti-TMG antibodies (Calbiochem) or control, uncoupled beads. The
beads were washed with 20 mM HEPES pH 7.9, 420 mM NaCl, 1.5 mM
MgCl2, 0.2 mM EDTA, 10% glycerol. The remaining lysate (unbound
fraction) was precipitated with 20% trichloroacetic acid. The beads and
unbound lysate were separated on an 8% SDS–polyacrylamide gel and
transferred to nitrocellulose membranes for immunoblotting with anti-
GFP and anti-Sm (Y12) antibodies.
Fixation and immunofluorescence
Cells were washed in PBS and fixed for 5 min in 3.7% (w/v)
paraformaldehyde in CSK buffer (10 mM PIPES pH 6.8, 10 mM NaCl,
300 mM sucrose, 3 mM MgCl2, 2 mM EDTA) at room temperature. Per-
meabilisation was performed with 1% Triton X-100 in PBS for 15 min at
room temperature. Immunofluorescence staining was carried out as
described [55]. Antibodies used were anti-Sm monoclonal antibody
(Y12) [36] (dilution 1:500) and 204,10 rabbit polyclonal anti-p80 coilin
antibody [43] (dilution 1:350). TRITC-conjugated goat anti-mouse and
Cy5-conjugated goat anti-rabbit secondary antibodies were used
(Jackson Immunochemicals). Fluorescence microscopy of fixed cells
was carried out using a Zeiss LSM 410 confocal laser-scanning micro-
scope. Excitation wavelengths were 488 nm (EGFP/EYFP), 543 nm
(TRITC) and 633 nm (Cy5).
Microinjection of constructs expressing fluorescent-protein-
tagged Sm, and observation of live cells
Plasmid DNA was diluted to 20 µg/ml with 100 mM glutamic acid
pH 7.2 (with citric acid), 140 mM KOH, 1 mM MgSO4 and 1 mM DTT
before injection into living MCF-7 or HeLa cells using an Eppendorf
5242 microinjector. Cells were maintained at 37ºC in a POC chamber
(Helmut Saur) in Dulbecco’s modified Eagles’ medium without phenol
red. Time-lapse sequences were taken using a Zeiss axioplan epifluo-
rescence microscope equipped with a KAF-1600, 1532 × 1025 pixel
cooled CCD camera (Digital Pixel Advanced Imaging Systems) using IP
lab image acquisition software. Exposure times of 200 msec were used.
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